Icon Group and Healthscope bring comprehensive cancer care closer to Tasmanian patients

This centre is part of Icon and Healthscope’s partnership to increase access to radiation oncology for patients across seven Healthscope hospitals.

The Icon Cancer Centre offers both chemotherapy and radiation therapy treatments, with radiation oncology services offered for both private and public patients, and no-gap treatment for privately insured patients within the day oncology hospital. This will be supported by chemotherapy compounding and pharmacy businesses within the wider Icon Group.

Research shows that cancer incidence and mortality rates are disproportionately high in Tasmania compared with other Australian states, with the nation’s highest cancer incidence reported in Queensland (532 per 100,000) and Tasmania (517 per 100,000) from 2008-2012, and the greatest cancer mortality rates observed in the Northern Territory (216 per 100,000) and Tasmania (199 per 100,000) for the same period.

Managing Director and CEO of Healthscope, Robert Cooke, said the opening of the Hobart centre is representative of Healthscope’s ongoing commitment to providing the best quality healthcare for its patients.

“Our partnership with Icon Group provides our patients with access to world’s best practice oncology technology and treatments to support their treatment journey,” Mr Cooke said.

“I am extremely proud that Healthscope continues to expand our oncology treatment offering across Australia, providing cancer patients with access to the highest standards of care, especially in those areas that need it most.”

Icon Group’s national partnership with Optimise Allied Health, will see the centre provide a comprehensive, multidisciplinary approach to supporting Tasmania’s cancer patients.

Icon has invested $200 million in cancer care services across the nation, with their sights set on providing more Australians with exceptional care on their door step, supported by cutting-edge technology.